72 related articles for article (PubMed ID: 1356730)
1. Pharmacokinetics of azelastine and its active metabolite, desmethylazelastine, in guinea pigs.
Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
Drug Metab Dispos; 1992; 20(4):530-5. PubMed ID: 1356730
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of [14C]azelastine in guinea pigs.
Yang JT; Wong KK; Kucharczyk N; Sofia RD
Drug Metab Dispos; 1992; 20(4):536-40. PubMed ID: 1356731
[TBL] [Abstract][Full Text] [Related]
3. High performance liquid chromatographic determination of azelastine and desmethylazelastine in guinea pig plasma and lung tissue.
Langevin CN; Pivonka J; Wichmann JK; Kucharczyk N; Sofia RD
Biomed Chromatogr; 1993; 7(1):7-11. PubMed ID: 8094306
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and pharmacokinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung.
Chand N; Adusumalli VE; Nolan K; Diamantis W; Wichmann JK; Pivonka J; Langevin CN; Wong KK; Kucharczyk N; Sofia RD
Allergy; 1993 Jan; 48(1):19-24. PubMed ID: 8096126
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and lung localization of [14C]azelastine in guinea pigs.
Wong KK; Yang JT; Kucharczyk N; Sofia RD
Drug Metab Dispos; 1992; 20(4):525-9. PubMed ID: 1356729
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the new antiasthma and antiallergy drug, azelastine, in pediatric and adult beagle dogs.
Adusumalli VE; Wichmann JK; Wong KK; Kucharczyk N; Sofia RD
Biopharm Drug Dispos; 1993 Apr; 14(3):233-44. PubMed ID: 8098227
[TBL] [Abstract][Full Text] [Related]
7. Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
Riethmüller-Winzen H; Peter G; Büker KM; Romeis P; Borbe HO
Arzneimittelforschung; 1994 Oct; 44(10):1136-40. PubMed ID: 7818588
[TBL] [Abstract][Full Text] [Related]
8. Disposition of acrivastine in the male beagle dog.
McNulty MJ; Deal DL; Nelson FR; Weller S; Chandrasurin P; Shockcor J; Findlay JW
Drug Metab Dispos; 1992; 20(5):679-87. PubMed ID: 1358572
[TBL] [Abstract][Full Text] [Related]
9. Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability.
Beauregard C; Stephens D; Roberts L; Gamache D; Yanni J
J Ocul Pharmacol Ther; 2007 Aug; 23(4):315-20. PubMed ID: 17803429
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
12. Changes in aeroallergen-induced pulmonary mechanics in actively sensitized guinea pig: inhibition by azelastine.
Chand N; Nolan K; Sofia RD; Diamantis W
Ann Allergy; 1990 Feb; 64(2 Pt 1):151-4. PubMed ID: 1968325
[TBL] [Abstract][Full Text] [Related]
13. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol.
Buttar HS; Moffatt JH; Bura C
J Toxicol Environ Health; 1988; 24(1):1-18. PubMed ID: 3373560
[TBL] [Abstract][Full Text] [Related]
14. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508
[TBL] [Abstract][Full Text] [Related]
16. Disposition of 2-mercaptobenzothiazole and 2-mercaptobenzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically.
el Dareer SM; Kalin JR; Tillery KF; Hill DL; Barnett JW
J Toxicol Environ Health; 1989; 27(1):65-84. PubMed ID: 2724369
[TBL] [Abstract][Full Text] [Related]
17. Effect of azelastine on the down regulation of beta-adrenoceptors in guinea pig lung.
Yin KS; Hayashi K; Taki F; Watanabe T; Takagi K; Satake T
Arzneimittelforschung; 1991 May; 41(5):525-7. PubMed ID: 1680326
[TBL] [Abstract][Full Text] [Related]
18. Studies of metabolic fate of a new antiallergic agent, azelastine (4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride).
Tatsumi K; Ou T; Yamada H; Yoshimura H
Jpn J Pharmacol; 1980 Feb; 30(1):37-48. PubMed ID: 6105223
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Barbhaiya RH; Dandekar KA; Greene DS
Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
[TBL] [Abstract][Full Text] [Related]
20. Effect of azelastine hydrochloride on vascular permeability in hypersensitivity reaction skin site in guinea pig.
Tanigawa T; Honda M; Miura K
Arzneimittelforschung; 1981; 31(8):1212-5. PubMed ID: 6117291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
